Skip to main content

Table 2 Current clinical trials to assess NTZ for treatment of COVID-19

From: Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?

COVID-19-related clinical trials Country Status
NTZ with ivermectin vs ivermectin with chloroquine Egypt Recruiting
NTZ for moderate case hospitalized patients Brazil Recruiting
NTZ for post-exposure prophylaxis in healthcare workers vs placebo vs dietary supplement USA Recruiting
NTZ 500 mg oral tablet Mexico Recruiting
NTZ vs hydroxychloroquine Mexico Recruiting
NTZ vs favipiravir vs chloroquine Egypt Recruiting
NTZ vs placebo Egypt Recruiting
\